Menu
Log in


Log in

NewS

If you have news that you would like distributed via HUPO's website, newsletter, or social media channels, please email office(at)hupo.org.

  • 02 Jun 2022 9:48 AM | Anonymous member (Administrator)

    The June HUPOST is now available....See important information about HUPO's Statement on Ukraine, World Congress, Awards Deadline, ETC and ECR updates....and much more!

  • 31 May 2022 7:34 AM | Anonymous member (Administrator)

    Blandine Chazarin, PhD is currently a postdoctoral scientist in Jennifer Van Eyk's lab at Cedars-Sinai Medical Center in Los Angeles (CA, USA). Previously she studied biology at Paul Sabatier University (Toulouse, France) prior advanced training in proteomics and mass spectrometry at Lille 1 University (Lille, France). She obtained a PhD using mass spectrometry to better understand hibernating brown bear physiology to path the way of therapeutic against muscle atrophy at LSMBO (Strasbourg, France). She is the former president of the youth club of the proteomic French Society and organized yearly meeting dedicated to young scientists in proteomics. Now, she is involved in postdoctoral scientist society at Cedars-Sinai and developed single cell proteomic approach applied to cardiac cells proteome analysis.

    Vision for ETC: Being an early career scientist can be challenging and Universities are not teaching how to evolve in science. It’s time to form our next generations of scientists by sharing trainings, advertising incoming meetings and provide additional information about grants and networking.

    Ben Collins, PhD is currently a Reader (equiv. Assoc. Prof.) in the School of Biological Sciences, Queen’s University of Belfast, UK (since 2019). His research focuses on broadly on 3 topics: (i) method development and applications in data independent acquisition mass spectrometry; (ii) method development and applications in the analysis of protein interaction networks and protein complexes; and (iii) applications of these strategies in host-pathogen biology and innate immunity. Ben Collins’s PhD was completed at University College Dublin in 2009 where he remained for 1 year as the Agilent Technologies Newman Fellow (postdoctoral) in Quantitative Proteomics. He moved to the Institute of Molecular Systems Biology at ETH Zurich in Autumn 2010 as postdoctoral researcher under the supervision of Prof. Ruedi Aebersold, where his research focused on the application of quantitative interaction proteomics in signaling and the development of DIA/SWATH mass spectrometry. Following this Ben Collins was a Group Leader and SNF Ambizione Fellow at IMSB, ETH Zurich with a focus on applying methods developed as a postdoc to relevant problems in host-pathogen biology.

    Vision for ETC:  Training and education are at the heart of HUPO activities, so I am excited to be involved in the effort to revitalize this initiative. My view is that there are many high-quality educational activities ongoing organized by independent groups and a part of our effort should be to make people aware of these courses in an organized way, and to distribute videos/materials as widely as possible where available. We should also aim to complement the current offerings with HUPO-organized courses on prioritized topics. Key to our success will be to reach proteomics-focused scientists but also beyond into the broader life science community where we can have tremendous impact.

    Deepti Jaiswal Kundu, PhD works as a Scientific Curator at EMBL-EBI, Cambridge, UK. Before joining EMBL-EBI, she studied botany, psychology, and bioinformatics in India, before doing a PhD in Cheminformatics in the Czech Republic. After successfully defending her thesis in 2015 Deepti Jaiswal Kundu moved to Cambridge, UK and took a break of briefly 2 years to have daughter. She joined EBI in 2018.  As a Scientific Curator, Deepti Jaiswal Kundu is responsible to check and validate new datasets submitted to the PRoteomics IDEntifications Database (PRIDE) - the world’s largest public database dedicated to mass spectrometry-based proteomics. Furthermore, she curates the datasets for further reanalysis and integration to other bioinformatic resources in EBI.

    Vision for ETC:  I would like ETC to reach more people and encourage students/scientists to participate in training programs, conferences, and meetings.

    Qingsong Lin, PhD is a Principal Research Fellow (Research Associate Professor) of the Department of Biological Sciences, National University of Singapore (NUS). He is the Director of the Protein and Proteomics Centre (PPC), NUS. Besides, he is the President of the Singapore Society for Mass Spectrometry (SSMS) since 2017. His expertise lies in applications of mass spectrometry in proteins and proteomics, extended to other biomolecules. His research interests are mainly in disease biomarker discovery and disease mechanism, drug target identification and mechanism of action studies, as well as the application of mass spectrometry and quantitative proteomics technologies to address various biological questions.

    Vision for ETC: To grow HUPO ETC as the world’s most comprehensive proteomics resource; to educate and train proteomics scientists from fundamental to advanced levels.

    Yansheng Liu, PhD is an Assistant Professor in the Department of Pharmacology at Yale University School of Medicine. His research group is interested in DIA-MS and has combined DIA with SILAC and phosphoproteomics for studying fundamental biological questions in cell signaling.

    Vision for ETC:  I believe the new HUPO ETC should engage the next generation of scientists and is eager to organize workshops in which young scientists, such as first-authors in manuscripts, can present and learn from each other.

    Brian Searle, PhD is an Assistant Professor at the Ohio State University Medical Center in the Department of Biomedical Informatics and a member of the Pelotonia Institute for Immuno-Oncology (PIIO). Brian received his chemistry BA at Reed College in 2001. In 2004, he co-founded Proteome Software with Mark Turner and Dr. Ashley McCormack to produce and distribute cutting-edge data analysis software for proteomicists. In 2014, he returned to academia to earn his PhD with Dr. Michael MacCoss at University of Washington, where he developed methods to detect and quantify proteins and phosphosites using mass spectrometry. His lab at PIIO spans the intersection of proteomics, mass spectrometry, bioinformatics, and technology development to study human genetic variation in the backdrop of cancer.

    Vision for ETC:  I am excited to see the ETC produce the best available educational resources for proteomicists of all skill levels to learn new technologies, and to give early-career proteomicists a chance to interact with top-level researchers and grow their careers.

    Low Teck Yew, PhD is an associate professor and senior research fellow located at the UKM Medical Molecular Biology Institute (UMBI) which is affiliated to the National University of Malaysia (UKM), leading the cancer proteomics and metabolomics group. Before that, he worked at Netherlands Proteomics Centre (NPC) in Utrecht University in the Netherlands. His research interests include bridging (phospho)proteomics with clinics and cancer proteogenomics.

    Vision for ETC: I hope to connect researchers in southeast Asia (SEA) to the international community in proteomics research and enhance the exposure of this region with respect to education and training. I also wish to share some of the special research topics in this region, which has its own rich and unique biodiversity, to international researchers.

  • 30 May 2022 10:49 PM | Anonymous member (Administrator)

    The HUPO Early Career Researcher (ECR) Initiative is an international community of early career researchers in proteomics, whose mission is to provide networking and career development opportunities for aspiring researchers. To help achieve this, the ECR Initiative organizes panel discussions to foster professional development and a space for mentorship. In the upcoming panel discussion, we will be covering the topic of scientific collaborations.

    Scientific collaborations can bridge disciplines, expertise, and countries to produce innovative research. Certainly, the COVID-19 pandemic has highlighted the importance of collaborating and has also changed the way scientists across various disciplines collaborate. But how do you collaborate successfully and effectively?

    Join us on Wednesday June 29th at 10:00PM GMT for the HUPO ECR online panel discussion, "Choosing and Managing Collaborations: The Do's and Don'ts". We will be joined by three experienced collaborators who will share valuable lessons learned on collaborating:

    • Dr. Vera Ignjatovic – Murdoch Children's Research Institute, Australia
    • Dr. John R. Yates III – Scripps Research, USA
    • Dr. Jennifer Geddes-McAlister – University of Guelph, Canada

    They will be sharing their input on how to have a successful career of collaborations. You won’t want to miss it!

    REGISTER HERE

  • 09 May 2022 9:14 AM | Anonymous member (Administrator)

    The Human Proteome Organization (HUPO) condemns, in the strongest terms, the military invasion of Ukraine by the Russian Federation, and deplores the resulting loss of life and humanitarian impact.

    We urge all HUPO members to offer opportunities for support, scientific research and collaboration to Ukrainian scientists, whether abroad,  displaced or under threat in their home country, and recommend highlighting these opportunities through HUPO channels as well as portals like https://scienceforukraine.eu/.

    As a global scientific organisation, HUPO supports the principles of the universality of science (https://council.science/5-universality-of-science). It is therefore key to note that our colleagues in Russia will maintain their individual positions and roles within HUPO, and will continue to have, as individuals, full access to all HUPO information and activities. Indeed, as a scientific organisation, with engagement, inclusivity, and transparency at our core, we do not condone any actions by anyone against any individuals simply because of their country of origin or residence.

  • 02 May 2022 3:59 PM | Anonymous member (Administrator)

    The May HUPOST is now available!  Check out lots of interesting info and articles...

  • 05 Apr 2022 4:26 PM | Anonymous member (Administrator)

    April HUPOST is now available -- Catch all the important info and updates!

  • 01 Apr 2022 5:02 PM | Anonymous member (Administrator)

    On Friday, May 13, following the 3-day 2nd Joint Meeting of Spanish, French and Portuguese Proteomics Societies, the Chromosome Centric Human Proteome Project (C-HPP) announces the 25th C-HPP Workshop on “Accelerating the HPP Grand Challenge”.

    This satellite workshop is open and free to all participants of ProteoVilamoura. Agenda: https://www.hupo.org/News/12690881

    If you want to attend, just register on our website: https://proteo-vilamoura.sci-meet.net/ by accessing “FEEs” on your personal area, select the C-HPP Satellite Workshop and save.

    Location: Forum Dom Pedro Vilamoura Main Conference Hall

    Date:  Friday May 13, 2022   Time: 14:00 – 17:00

    Agenda:

    • Welcome by Chris Overall, Chair C-HPP 14:00-14:05
    • Lydie Lane, Co-Chair C-HPP, Chair Chromosome 2 Team:  "Update on Progress in Completing the Human Proteome, neXtprot Release 2022" (20 + 5 minutes)" 14:05-14:30
    • Gong Zhang, Chair Chromosome 8 C-HPP Team: "The discovery, function and evolution of the hidden human proteome translated from "non-coding RNAs" (20 + 5 minutes) 14:30-14:55
    • Marina Gay:  "How Top-down Proteomics Can Contribute to the HPP" (20 + 5 minutes) 14:55-15:20
    • Charles Pineau:  "The HPP Grand Challenge" (20 + 5 minutes) 15:20-15:45
    • 75 minutes Open Discussion and Goal Setting, Chairs Chris Overall and Charles Pineau including the use of DIA for missing proteins with Ulrich auf dem Keller, Chair Chromosome 21, 15:45-17:00
    • Meeting Close 17:00
    • Refreshments and dinner at a local restaurant, at own expense.
    The conference hotel and nearby hotels have special rates for ProteoVilamoura participants. You must make your reservation directly with the hotels with the reservations codes listed here: https://proteo-vilamoura.sci-meet.net/travel-accommodation
  • 01 Apr 2022 2:53 PM | Anonymous member (Administrator)

    The ECR is delighted to welcome several new members from all over the world. They will play key organizing roles in ECR activities such as mentoring sessions, networking hours, online panel discussions, competitions and more.

    Dr. Sayantani Chatterjee is a Post-Doctoral Associate in Prof. Joseph Zaia’s research group in Boston University School of Medicine in Boston, Massachusetts, USA. Her current research focuses on exploring viral glycoproteomics, particularly of influenza and SARS-CoV-2 viruses, using high-throughput mass spectrometry, to aid in the development of effective therapeutics. Previously, she completed her PhD under the supervision of Dr. Morten Thaysen-Andersen from Macquarie University, Sydney, Australia where she investigated the structure, function, and involvement of mannose-terminating glycoproteins in cancer, innate immunity and pathogenic infections.

    Ireshyn Govender is a senior researcher in the Molecular Diagnostics and Omics group at the Council for Scientific and Industrial Research (CSIR), South Africa. He started his career at CSIR in 2013 as a candidate researcher, where his research focused on clinical proteomics in HIV/AIDS-based precision medicine. His Ph.D. was completed in 2019 at the University of the Witwatersrand. Ireshyn is also an application specialist at ReSyn Biosciences where he develops novel sample preparation workflows for biofluid-based clinical proteomics. He is a member of clinical research groups that use proteomics to address diseases that are prominent in South Africa and underrepresented populations by identifying prognostic and/or diagnostic protein biomarker panels. He is also an executive committee member of the South African Association for Mass Spectrometry (SAAMS).

    Charlotte Hutchings is a PhD student in Kathryn Lilley's laboratory at the University of Cambridge. Having completed her BSc and MSc at Imperial College London, Charlotte's primary interest lies in the optimization of gene therapy vectors. It was this interest that led Charlotte to enter the world of proteomics where she now applies novel spatial proteomics methods to understand the mechanism by which adeno-associated viral vectors (used in approved gene therapies) are secreted from HEK293 producing cells. The aim of this work is to optimize the manufacturing of such vectors in collaboration with AstraZeneca. Outside of her project, Charlotte participates in public outreach events and acts as a STEM Ambassador for the North East region of England. She is also a member of the British Society for Proteome Research and the Biochemical Society and is continuing to expand her network. 

    Santosh Misal is a Proteomics Scientist at the Laboratory of Malaria, Immunology, and vaccinology (LMIV), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda MD, USA. He manages a small proteomics facility and provides support to the LMIV investigators for the malaria biomarker discovery and vaccine development pipeline. He utilizes various proteomics approaches including chemical labeling, crosslinking, and single-cell protein analysis to identify parasite protein targets for vaccine development. Before joining NIH, he was a postdoctoral scientist at Brigham Young University and Indiana University Bloomington. Santosh obtained his Ph.D. degree in Biochemistry from Savitribai Phule Pune University, India with a strong interest in protein analysis.

    Sri Ramarathinam has over 15 years of cumulative experience in proteomics and immunopeptidomics. After completing Master of Biotechnology from RMIT University, he worked as a Research Assistant at the University of Melbourne for four years in proteomics, before completing PhD in HIV immunobiology from Monash University. He is currently working as a post-doctoral research fellow at the immunopeptidomics lab headed by Prof Tony Purcell at Biomedicine Discovery Institute (Monash). His research interests include development of new methodologies to address questions in virology, antigen processing and presentation, cancer and autoimmunity. He is also passionate about ECR well-being and is part of institute- and faculty-level ECR committees.

  • 02 Mar 2022 12:06 PM | Deleted user

    March issue of the HUPOST is now available. Lots of updates to check out!


  • 03 Feb 2022 8:10 PM | Deleted user

    Catch up on HUPO news with the February HUPOST



The Human Proteome Organization is a 501(c)(3) tax exempt non-profit organization registered in the state of New Mexico.  |  © 2001-2022 HUPO. All rights reserved. 

Powered by Wild Apricot Membership Software